698 Safety and tolerability of magrolimab in combination with taxanes in patients with solid tumors

• Rohit Joshi,
• Sylvia Adams,
• Jiang Shao,
• Wen Xu,
• Joanne Chiu,
• William Lawler,
• Muhammad Furqan,
• Ulka N Vaishampayan,
• Oscar Juan-Videl,
• Natalie Rainey,
• Bruno Fang,
• Brian Vicuna,
• Fadi Shihadeh,
• Ann Chen,
• Aoife Sills,
• Estibaliz Lopez

Affiliations

Rohit Joshi

Cancer Research and Clinical Trials, Adelaide Oncology and Haematology, North Adelaide, South Australia, Australia

Sylvia Adams

Perlmutter Cancer Center, New York University Langone, New York, New York, USA

Jiang Shao

10Gilead Sciences, Inc, Foster City, USA

Wen Xu

10Princess Alexandra Hospital, Brisbane, QLD, Australia

Joanne Chiu

Medicine, University of Hong Kong, Hong Kong, Hong Kong

William Lawler

6 Dyke Farm, Penrith, UK

Muhammad Furqan

2University of Iowa, Carver College of Medicine, Iowa City, IA, USA

Ulka N Vaishampayan

8Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA

Oscar Juan-Videl

1Hospital Universitari i Politècnic la Fe, Valencia, Spain

Natalie Rainey

6Queensland Government – Cairns and Hinterland Hospital and Health Service, Queensland, QLD, Australia

Bruno Fang

7Astera Cancer Care, East Brunswick, NJ, USA

Brian Vicuna

9Comprehensive Cancer Centers, Las Vegas, NV, USA

Fadi Shihadeh

11Gilead Sciences, Inc., Foster City, CA, USA

Ann Chen

11Gilead Sciences, Inc., Foster City, CA, USA

Aoife Sills

11Gilead Sciences, Inc., Foster City, CA, USA

Estibaliz Lopez

11Gilead Sciences, Inc., Foster City, CA, USA